RABLERA Trademark

Trademark Overview

On Friday, November 5, 2004, a trademark application was filed for RABLERA with the United States Patent and Trademark Office. The USPTO has given the RABLERA trademark a serial number of 79007944. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 5, 2024. This trademark is owned by Novartis AG. The RABLERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or prevention of diseases of the nervous system

General Information

Serial Number79007944
Word MarkRABLERA
Filing DateFriday, November 5, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 5, 2024
Registration Number3036036
Registration DateTuesday, December 27, 2005
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment or prevention of diseases of the nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Thursday, June 9, 2005ASSIGNED TO EXAMINER
Thursday, June 23, 2005ASSIGNED TO LIE
Thursday, June 23, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 14, 2005NOTICE OF PUBLICATION
Thursday, February 17, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 18, 2005NEW APPLICATION ENTERED
Friday, June 10, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 17, 2005ASSIGNED TO LIE
Tuesday, December 27, 2005REGISTERED-PRINCIPAL REGISTER
Friday, June 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 13, 2013CANCELLED SECTION 71
Tuesday, October 4, 2005PUBLISHED FOR OPPOSITION
Thursday, November 9, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 21, 2017NOTIFICATION PROCESSED BY IB
Monday, June 2, 2025DEATH OF INTERNATIONAL REGISTRATION
Monday, June 2, 2025NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, June 4, 2015INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, May 13, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 22, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, May 22, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

rablera nervous system diseases prevention preparations treatment pharmaceutical